![Treating Hearing Loss: Interview with Carl LeBel, PhD, Chief Development Officer, Frequency Therapeutics Treating Hearing Loss: Interview with Carl LeBel, PhD, Chief Development Officer, Frequency Therapeutics](https://hearinghealthmatters.org/wp-content/uploads/2020/02/hh2020biotech.jpg)
Treating Hearing Loss: Interview with Carl LeBel, PhD, Chief Development Officer, Frequency Therapeutics
![Phase 1b study of FX-345, new hearing loss drug candidate from Frequency Therapeutics, planned for second half of 2022 : r/tinnitusresearch Phase 1b study of FX-345, new hearing loss drug candidate from Frequency Therapeutics, planned for second half of 2022 : r/tinnitusresearch](https://external-preview.redd.it/lTfi9qn_AgVNXA7-RocyCBjCH8O2-mQZ_Q99f6tGi1M.jpg?auto=webp&s=51ac08570f07092b76808f1350ad585dc17c20e7)
Phase 1b study of FX-345, new hearing loss drug candidate from Frequency Therapeutics, planned for second half of 2022 : r/tinnitusresearch
![Otonomy, a dark horse in the biomedical field? The company's executives talk about the revival of hearing science and cutting edge solutions for hearing and tinnitus (OTO-313, OTO-413, gene therapy...) : r/tinnitusresearch Otonomy, a dark horse in the biomedical field? The company's executives talk about the revival of hearing science and cutting edge solutions for hearing and tinnitus (OTO-313, OTO-413, gene therapy...) : r/tinnitusresearch](https://external-preview.redd.it/lAY7nkNSBVzW1DGwzWi62P7DWgY-d0iF_9AOthh0Zog.jpg?width=640&crop=smart&auto=webp&s=e1240ce450ed54b2046a756dd83be52ded211391)
Otonomy, a dark horse in the biomedical field? The company's executives talk about the revival of hearing science and cutting edge solutions for hearing and tinnitus (OTO-313, OTO-413, gene therapy...) : r/tinnitusresearch
![Frequency Therapeutics Presenting @ Baird's 2022 Health Conference - (14th September 2022) - YouTube Frequency Therapeutics Presenting @ Baird's 2022 Health Conference - (14th September 2022) - YouTube](https://i.ytimg.com/vi/5tb6XMzsQQ8/maxresdefault.jpg)
Frequency Therapeutics Presenting @ Baird's 2022 Health Conference - (14th September 2022) - YouTube
![Frequency Therapeutics to present major FX-322 update on September 18, 2019 at AAO-HNSF Annual Meeting in New Orleans - Tinnitus Treatment Report Frequency Therapeutics to present major FX-322 update on September 18, 2019 at AAO-HNSF Annual Meeting in New Orleans - Tinnitus Treatment Report](https://tinnitustreatmentreport.com/wp-content/uploads/2019/05/fx-322-upcoming-september-2019-presentation-update-1024x735.png)